Trump administration advances plan for peptide drugs favored by RFK Jr.

U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections that have become popular among followers of Health Secretary Robert F. Kennedy Jr. and other wellness influencers. Kennedy's Department of Health and Human Services submitted a peptides "interim access policy" to the White House for review, according to a posting Thursday on a government website. The plan was sent to the Office of Management and Budget, which reviews federal rules and regulations with the potential for significant economic impact. HHS officials did not immediately respond to requests for comment Thursday afternoon.